This post was originally published on Medscape
You will shortly be re-directed to the publisher's website
A study of ruxolitinib cream in patients with lichen planus indicated that the topical JAK inhibitor is a promising potential treatment for cutaneous lichen planus that is also well tolerated.
Medscape Medical News